MAPT and Cognitive impairment: Given that imaging markers of brain hypometabolism and tau deposition are closely linked with subsequent cognitive impairment, the steeper decline in cognitive performance among women with higher levels of plasma p-tau181 may be partly due to the presence of more established levels of tau deposition and neurodegeneration.